Singler biztosítási steinach. Tájékoztató az utasbiztosítások érvényességéről

Flow cytometric immunophenotypic analysis of cases of multiple myeloma. American Journal of Clinical Pathology ; — Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. Ismerősök südkurier of Immunology ; — Human CD38, a cell-surface protein with multiple functions.

Human CD a r evolutionary story of enzymes and receptors. Leukemia Research ; 1— Leukemia Research ; — Immunotherapies targeting CD38 in Multiple Myeloma.

Oncoimmunology ; 5: e CD38 antibodies in multiple myeloma: back to the future. Blood ; 13— Erythrocyte CD38 as a prognostic marker in cancer.

Hematology ; — Biochemical and Biophysical Research Communications ; — When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion ; — International validation of a dithiothreitol DTT -based method to resolve the daratumumab interference with blood compatibility testing. Resolving the daratumumab interference with blood compatibility testing.

Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference. Immunohematology ; 22— Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma.

Transfusion ; Daratumumab and Blood-Compatibility Testing.

The New England Journal of Medicine ; —